Novel Microdevices: Funding, Investors & Team (Oct 2026)
Novel Microdevices is a start-up in the medical device industry that specializes in creating a handheld point-of-care medical device for molecular diagnostics. The device utilizes microfluidics to analyze raw biological samples right at the point of care, providing results in just 30 minutes. This allows healthcare professionals to obtain high-quality results without the need for a traditional laboratory setting. Founded by Andrea Pais in 2014, the company is based in Baltimore, Maryland.
Novel Microdevices has raised $6.2M across 5 funding rounds on record, the most recent an undisclosed round of $1.0M announced in Apr 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Novel Microdevices Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Novel Microdevices Funding Rounds
Novel Microdevices raised $1.4M in an undisclosed round announced in Aug 2023.
1.3 years later, an undisclosed round of $2.7M was announced in Nov 2024.
3 months later, an undisclosed round of $500k was announced in Feb 2025.
4 months later, an undisclosed round of $630k was announced in Jun 2025.
10 months later, an undisclosed round of $1.0M was announced in Apr 2026.
Novel Microdevices Founders and Leadership Team
No contact details are on record for this team yet.
Novel Microdevices Funding Compared to Other Biotechnology Startups
Novel Microdevices' latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Novel Microdevices in Biotechnology and Baltimore
Companies Similar to Novel Microdevices
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Novel Microdevices Funding FAQs
What does Novel Microdevices do?
Novel Microdevices is a start-up in the medical device industry that specializes in creating a handheld point-of-care medical device for molecular diagnostics. The device utilizes microfluidics to analyze raw biological samples right at the point of care, providing results in just 30 minutes. This allows healthcare professionals to obtain high-quality results without the need for a traditional laboratory setting. Founded by Andrea Pais in 2014, the company is based in Baltimore, Maryland.
How much funding has Novel Microdevices raised?
Novel Microdevices has raised $6.2M across 5 rounds on record. The most recent is an undisclosed round of $1.0M announced in Apr 2026.
When did Novel Microdevices last raise funding?
Novel Microdevices' most recent funding round on record is an undisclosed round of $1.0M, announced in Apr 2026.
Who founded Novel Microdevices?
FundedIQ lists Andrea Pais (Founder) at Novel Microdevices.
Where is Novel Microdevices headquartered?
Novel Microdevices is based in Baltimore, Maryland, United States.
How many employees does Novel Microdevices have?
Novel Microdevices is in the 11-50 employee band.
How does Novel Microdevices' funding compare to other Biotechnology startups?
Novel Microdevices' latest round of $1.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Novel Microdevices Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Novel Microdevices is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.